Organon & Co. (OGN)
8.54
-0.06
(-0.70%)
USD |
NYSE |
Jan 30, 16:00
8.535
0.00 (0.00%)
After-Hours: 20:00
Organon Market Cap : 2.220B for Jan. 30, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 273.69B |
| Rockwell Medical, Inc. | 42.16M |
| Plus Therapeutics, Inc. | 31.35M |
| Geron Corp. | 874.55M |
| Regeneron Pharmaceuticals, Inc. | 77.93B |
Market Cap Related Metrics
| PE Ratio | 4.439 |
| PS Ratio | 0.353 |
| Price to Book Value | 2.451 |
| Price to Free Cash Flow | 3.719 |
| Price | 8.54 |
| Earnings Yield | 22.53% |
| Operating PE Ratio | 1.694 |
| Normalized PE Ratio | 3.984 |